Manfred Gröppel und 4Sc - Info zur Person

(1 - 15 von 26

)

Immunic acquires 4SC's immunology portfolio (news with additional ...sg.news.yahoo.com › ...

sg.news.yahoo.com

· Dr. Manfred Gröppel, Immunic's co-founder and Chief Operating Officer, says: "We are delighted that we are able to acquire several ...

Immunic acquires 4SC's immunology portfolio, Immunic AG,...

www.lifepr.de

Immunic - Immunic acquires two promising drug development programs with validated targets known to be relevant in various immune and autoimmune diseases

DGAP-News: 4SC AG: 4SC verkauft Immunologie-Portfolio an Immunic...

www.finanznachrichten.de

Immunic Dr. Manfred Gröppel+ Veröffentlichung einer Corporate News/Finanznachricht, übermittelt durch DGAP ...

4SC sells immunology portfolio to Immunic - dgap.de

www.dgap.de

SC sells immunology portfolio to Immunic | 4sc | cancer | epigenetic |

LinkedIn: Manfred Gröppel - Deutschland | LinkedIn

Manfred Gröppel. Director Business Development at 4SC Location Munich Area, Germany Industry Biotechnology

Daniel Vitt - Biography

www.marketscreener.com

Daniel Vitt is a businessperson who founded 4SC AG and Brauhaus Germering GmbH and who has been at the helm of 5 different companies. Dr. Vitt holds the...

Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium...

link.springer.com

von A Muehler · · Zitiert von: 9 — Immunic AG, Am Klopferspitz 19Planegg-Martinsried, Germany. Andreas Muehler, Hella Kohlhof, Manfred Groeppel & Daniel Vitt. Authors. von A Muehler · · Zitiert von: 11 — Hella Kohlhof, Manfred Groeppel, and Daniel Vitt were all employed by 4SC AG, the study sponsor, during the time the COMPONENT study was ... › article

Immunic acquires 4SC's immunology portfolio (news with ...

uk.finance.yahoo.com

— Dr. Manfred Gröppel, Immunic's co-founder and Chief Operating Officer, says: "We are delighted that we are able to acquire several ... › news

4SC-101, a novel immunosuppressive drug, inhibits IL-17 and...

read.qxmd.com

Leo R Fitzpatrick, Ludwig Deml, Claudia Hofmann, Jeffrey S Small, Manfred Groeppel, Svetlana Hamm, Sylvia Lemstra, Johann Leban, Aldo Ammendola.

4SC‐101, a novel immunosuppressive drug, inhibits IL‐17 and...

www.semanticscholar.org

author={Leo R. Fitzpatrick and Ludwig Deml and Claudia Maria Hofmann and Jeffrey S. Small and Manfred Groeppel and Svetlana Hamm and Sylvia Lemstra ...

Immunic erwirbt das Immunologie-Portfolio der 4SC - Bayerns Investor...

bayernkapital.de

Dr. Manfred Gröppel, einer der Mitgründer und Chief Operating Officer bei Immunic, sagt: “Wir freuen uns, dass wir so qualitativ hochwertige und fortgeschrittene Arzneimittel-Entwicklungsprojekte erwerben konnten, deren Wirkmechanismen bereits in verschiedenen Immun- und Autoimmunerkrankungen Relevanz gezeigt hatten.